|
|
||||||||
The Journal of Immunology, Vol 155, Issue 8 4037-4043, Copyright © 1995 by American Association of Immunologists
ARTICLES |
O Criado Garcia, P Sanchez-Corral and S Rodriguez de Cordoba
Department of Immunology, Center for Biological Investigations (CSIC), Velazquez, Madrid, Spain.
Human C4b-binding protein (C4BP) controls activation of the complement system and inactivates the anticoagulant vitamin K-dependent protein S using two distinct polypeptides known as C4BP alpha and C4BP beta, respectively. C4BP presents three isoforms, alpha 7 beta 1, alpha 7 beta 0, and alpha 6 beta 1, the proportion of which depends on the relative levels of C4BP alpha and C4BP beta. To better understand the regulation of C4BP during the acute phase response we analyzed the C4BP isoforms in 23 serial samples of acute phase patients and characterized the effect of various acute phase cytokines on the expression of the C4BPA and C4BPB genes using Hep3B cells. We show that the elevation of C4BP during acute phase response leads to changes in the proportion of the C4BP isoforms. However, there are striking differences among acute phase individuals. Some of them present a pattern of induction that primarily affects the alpha 7 beta 0 isoform, whereas others present the opposite situation, increasing the C4BP beta-containing isoforms. In vitro studies demonstrate that IL-6, IL-1 beta, and INF-gamma increase the levels of both C4BP alpha- and C4BP beta-mRNAs, whereas TNF-alpha down-regulates these mRNAs. INF-gamma shows, in addition, a differential effect on the C4BP alpha- and C4BP beta-mRNAs. Differential modulation of the C4BPA and C4BPB genes has been postulated as an efficient mechanism to maintain steady concentrations of C4BP beta when C4BP is induced. A synergistic 10-fold induction of C4BP alpha-mRNA, but a marginal increase of C4BP beta-mRNA, was observed when INF-gamma was used together with TNF-alpha, suggesting that association of these cytokines is critical to avoid elevation of C4BP beta during the acute phase induction of C4BP.
This article has been cited by other articles:
![]() |
C. J.F. de Wolf, R. M.J. Cupers, R. M. Bertina, and H. L. Vos Interleukin-6 Induction of Protein S Is Regulated Through Signal Transducer and Activator of Transcription 3 Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2168 - 2174. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Sjoberg, L. A. Trouw, F. D. G. McGrath, C. E. Hack, and A. M. Blom Regulation of complement activation by C-reactive protein: targeting of the inhibitory activity of c4b-binding protein. J. Immunol., June 15, 2006; 176(12): 7612 - 7620. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Dahlback Successful Hunt for Quantitative Trait Locus in Thrombophilia Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 376 - 377. [Full Text] [PDF] |
||||
![]() |
L. Almasy, J. M. Soria, J. C. Souto, I. Coll, D. Bacq, A. Faure, J. Mateo, M. Borrell, X. Munoz, N. Sala, et al. A Quantitative Trait Locus Influencing Free Plasma Protein S Levels on Human Chromosome 1q: Results From the Genetic Analysis of Idiopathic Thrombophilia (GAIT) Project Arterioscler. Thromb. Vasc. Biol., March 1, 2003; 23(3): 508 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Oudin, M. T. Libyh, D. Goossens, X. Dervillez, F. Philbert, B. Reveil, F. Bougy, T. Tabary, P. Rouger, D. Klatzmann, et al. A Soluble Recombinant Multimeric Anti-Rh(D) Single-Chain Fv/CR1 Molecule Restores the Immune Complex Binding Ability of CR1-Deficient Erythrocytes J. Immunol., February 1, 2000; 164(3): 1505 - 1513. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |